Onset of Effect and Impact on Health-Related Quality of Life, Exacerbation Rate, Lung Function, and Nasal Polyposis Symptoms for Patients with Severe Eosinophilic Asthma Treated with Benralizumab (ANDHI): a Randomised, Controlled, Phase 3b Trial
Date
This item will be available on:
Authors
Mohan, Arjun
Harrison, Tim
Chanez, Pascal
Menzella, Francesco
Canonica, Giorgio Walter
Louis, Renaud
Cosio, Borja
Lugogo, Njira
Burden, Annie
Mcdermott, Lawrence